Form 4: Sotera Health CEO Michael Petras Reports Stock Transactions
SEC Form 4 Filing
Sotera Health's CEO, Michael B. Petras Jr., reports the acquisition and disposal of company stock and derivative securities, including transactions related to tax obligations and vesting of restricted stock units and performance stock units.
Summary
- Michael B. Petras Jr., CEO of Sotera Health Co, filed a Form 4 detailing changes in beneficial ownership of the company's stock.
- On March 2, 2025, shares were withheld to cover tax obligations related to the vesting of Restricted Stock Units (RSUs) from grants made in 2022, 2023 and 2024.
- Specifically, 27,990 shares were withheld at $12.47 per share related to the 2022 RSU grant, 31,872 shares were withheld at $12.47 per share related to the 2023 RSU grant, and 40,987 shares were withheld at $12.47 per share related to the 2024 RSU grant.
- On March 3, 2025, Petras acquired 298,953 RSUs and 149,476 Performance Stock Units (PSUs).
- Following these transactions, Petras directly owns 868,603 shares of common stock and indirectly owns 5,214,337 shares through a grantor trust and 39,243 shares through a family trust.
- Petras also holds options to purchase 544,509 shares at $14.59, 404,094 shares at $17.59, 2,108,356 shares at $6.37, 478,932 shares at $20.03, and 1,118,012 shares at $23.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but the continued holding of shares and granting of new equity suggest a neutral to slightly positive outlook.
Positives
- The granting of RSUs and PSUs to the CEO aligns his interests with those of the shareholders.
- The CEO's continued holdings of a significant number of shares and options demonstrates a long-term commitment to the company.
Future Outlook
The RSUs granted on March 3, 2025, generally vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026. The PSUs also vest annually in 60%, 20%, and 20% installments, respectively, commencing March 3, 2026, subject to performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's future prospects.
Comparison to Industry Standards
- Stock option and RSU grants are common compensation practices among publicly traded companies to incentivize executives.
- Vesting schedules, such as the one described for Sotera Health's RSUs and PSUs (60%, 20%, 20% annually), are typical in the industry.
- Companies like Steris, a competitor in the sterilization and contamination control market, also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The transactions reported may influence investor perception of management's confidence in the company.
- The vesting of RSUs and PSUs will result in dilution for existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/02/2022 | Date of original RSU grant related to tax withholding. |
| 11/07/2022 | Date of original stock option grant. |
| 03/06/2023 | Date of original RSU grant related to tax withholding. |
| 03/04/2024 | Date of original RSU and stock option grant related to tax withholding. |
| 09/12/2024 | Date of Form 4 filing with Power of Attorney exhibit. |
| 03/02/2025 | Date of tax withholding for RSU vesting. |
| 03/03/2025 | Date of RSU and PSU grants. |
| 03/04/2025 | Date of Form 4 filing. |
| 03/03/2026 | Commencement of RSU and PSU vesting. |
| 11/20/2030 | Expiration date of stock options. |
| 03/02/2032 | Expiration date of stock options. |
| 11/07/2032 | Expiration date of stock options. |
| 03/06/2033 | Expiration date of stock options. |
| 03/04/2034 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.